Phenotypes associated with this allele
|
Find Mice |
Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Lgr5tm1(cre/ERT2)Cle mutation
(1 available);
any
Lgr5 mutation
(57 available)
Rpap3tm1c(KOMP)Wtsi mutation
(0 available);
any
Rpap3 mutation
(34 available)
|
|
|
normal phenotype
|
• tamoxifen-treated mice are normal and survive for 3 weeks at least
|
|
Find Mice |
Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Rpap3tm1c(KOMP)Wtsi mutation
(0 available);
any
Rpap3 mutation
(34 available)
Tg(Vil1-cre/ERT2)23Syr mutation
(1 available)
Trp53tm1Tyj mutation
(12 available);
any
Trp53 mutation
(232 available)
|
|
|
digestive/alimentary system
|
• tamoxifen-treated mice exhibit a delay in epithelium shrinkage compared mice with at least one copy of wild-type Trp53
|
|
• in tamoxifen-treated mice after 7 days
|
|
Find Mice |
Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Rpap3tm1c(KOMP)Wtsi mutation
(0 available);
any
Rpap3 mutation
(34 available)
Tg(Vil1-cre/ERT2)23Syr mutation
(1 available)
|
|
|
digestive/alimentary system
|
• disorganized with focal crowding in tamoxifen-treated mice after 7 days
|
|
• in tamoxifen-treated mice after 6 days
|
|
• in tamoxifen-treated mice after 7 days
|
|
• in tamoxifen-treated mice after 6 days
|
|
• tamoxifen-treated mice exhibit reduction in proliferating stem cells and progenitors and increased apoptosis compared with control mice
• however, differentiated Paneth cells are normal
|
|
• after 6 days, tamoxifen-treated mice exhibit massive intestinal swelling with a transparent liquid or blood compared with control mice
|
growth/size/body
|
• in tamoxifen-treated mice after 6 days
|
immune system
|
• after 6 days, tamoxifen-treated mice exhibit massive intestinal swelling with a transparent liquid or blood compared with control mice
|
cellular
|
• in tamoxifen-treated mice after 7 days
|